{"id":"W2031152150","doi":"10.1016/j.urology.2009.12.031","title":"Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; BC Cancer Agency","funders":"","keywords":"Medicine; Sorafenib; Temsirolimus; Sunitinib; Everolimus; Bevacizumab; Internal medicine; Targeted therapy; Oncology; Axitinib; Vascular endothelial growth factor; Renal cell carcinoma; Cancer; Second-line therapy; Chemotherapy; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; VEGF receptors; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002537468,0.000272176,0.0007825724,0.0002447609,0.00001857708,0.000004908203,0.0001496036,0.0002630758,0.0007817337],"category_scores_gemma":[0.0002070668,0.0002041772,0.0003529573,0.000133949,0.0002057313,0.0000523671,0.00005700281,0.0006977472,0.00005400497],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003005926,"about_ca_system_score_gemma":0.0001200477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001519497,"about_ca_topic_score_gemma":0.0001157107,"domain_scores_codex":[0.9976388,0.000330182,0.0008733523,0.0004382566,0.0003223015,0.0003970931],"domain_scores_gemma":[0.9986907,0.0003040431,0.0001990768,0.0004640791,0.0001586316,0.000183493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001665669,0.001015208,0.9871146,0.00003553263,0.00009636024,0.0003322743,0.0002589625,0.000001016605,0.008729532,0.00001411766,0.00002727591,0.0007094134],"study_design_scores_gemma":[0.01107246,0.003119717,0.9676151,0.000002530493,0.0001420222,0.00001465932,0.000009993972,0.00002330618,0.01712491,0.00007778279,0.0006516343,0.0001458845],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981961,0.0001610646,0.00002896638,0.0001619547,0.0004437529,0.0006499577,0.00006546803,0.00001982,0.0002729554],"genre_scores_gemma":[0.9983729,0.00001232887,0.0006752544,0.000578588,0.0001622442,0.0000581593,0.00006914564,0.00004045366,0.00003092254],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01949954,"threshold_uncertainty_score":0.8559436,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02788989558493725,"score_gpt":0.3073046206455494,"score_spread":0.2794147250606122,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}